AtriCure ATRC Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 75%+0.3pp | 74.7%-0.5pp | 75.2%+0.8pp | 74.4%-0.6pp | |
| Free cash flow margin | 9%— | —— | —— | -11.8%-3.2pp | |
| Efficiency | |||||
| Asset turnover | 0.8×+0.1× | 0.8×+0.1× | 0.7×+0.1× | 0.6×+0.1× | |
| Inventory turnover | 1.7×+0.1× | 1.6×-0.1× | 1.7×-0.3× | 2×+0.1× | |
| Liquidity | |||||
| Current ratio | 4×+0.3× | 3.6×+0.1× | 3.6×-0.1× | 3.7×+0.2× | |
| Quick ratio | 3×+0.4× | 2.6×0.0× | 2.7×-0.2× | 2.9×+0.1× | |
| Cash ratio | 2.1×+0.4× | 1.7×+0.5× | 1.1×+0.1× | 1×+0.2× | |
| Leverage | |||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | |||||
| Book value per share | $10.30+5.0% | $9.82-2.5% | $10.07+0.8% | $9.99-5.0% | |
| Valuation | |||||
| Market capitalization | $1.43B-7.9% | $1.49B-11.9% | $1.69B-18.0% | $2.06B-35.4% | |
| Enterprise value | $1.36B-11.2% | $1.44B-14.2% | $1.68B-19.1% | $2.08B-35.5% | |
| Price / sales | 2.6×-0.6× | 3.2×-1.0× | 4.2×-2.0× | 6.2×-5.4× | |
| Price / book | 2.9×-0.5× | 3.2×-0.4× | 3.6×-0.9× | 4.5×-2.1× | |
| EV / sales | 2.5×-0.7× | 3.1×-1.1× | 4.2×-2.1× | 6.3×-5.5× | |
| Free cash flow yield | 3.7%— | —— | —— | -1.9%-1.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are AtriCure's profit margins?
- AtriCure (ATRC) runs a 75.6% gross margin and a -5.1% operating margin, with a -5.6% net margin.
- Where do AtriCure's ratios come from?
- Every ratio is computed from AtriCure's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
